Image source: The Motley Fool. Gilead Sciences (NASDAQ:GILD) Q1 2021 Earnings … standing by. Welcome to the Gilead Sciences first-quarter 2021 earnings conference … today without the vision of John Martin, Gilead's chief executive …

… . A real-life example is Gilead Sciences (NASDAQ:GILD), where management is … each has left their mark. John Martin, the company's CEO …

… and later with John Martin, who established Gilead Sciences, was key … and with John Martin, personally, the CEO of Gilead Sciences. The … of translational research. “John Martin unfortunately died and … inspired that move? “Gilead Sciences, one should say, and …

… name. Gilead Sciences, a USA-based biotechnology company of which John Martin was the … immune system caused by HIV. Gilead Sciences discovered an injectable drug, Lenacapavir … sex with men. This year, Gilead Sciences has signed agreements with six …

(Reuters) - Drugmaker Gilead Sciences Inc on Monday named Roche … Executive John Milligan and Chairman John Martin would step down at the …

(Reuters) - Drugmaker Gilead Sciences Inc (NASDAQ:GILD) named Roche … Executive John Milligan and Chairman John Martin would step down at the …

Gilead Sciences Inc. (GILD) said Monday that … the future," said John Martin, PhD, Chairman, Gilead Sciences Board of Directors. O …

Drugmaker Gilead Sciences Inc will name Roche Holding … Executive John Milligan and Chairman John Martin would step down at the …

Gilead Sciences (NASDAQ:GILD) announced last week … CEO John Milligan and Chairman John Martin will step down from their … owns shares of and recommends Gilead Sciences. The Motley Fool has a …

… as president and CEO of Gilead Sciences (NASDAQ: GILD) at the end … also announced that board chairman John Martin will step down. Martin will …